 This study demonstrated that a serological response to treatment with nephrotomox could be detected using an ELISA test for the F29 protein. This test may be useful as an early marker of response to antitropanosomal therapy for chagas disease. This article was authored by Rocio Rivera, Monica Ines Estiva, Aria Huang, and others.